Discover and read the best of Twitter Threads about #classicalhematology
Most recents (2)
Educational 🧵 on autoimmune hemolytic anemias (AIHA). Not medical advice. Always open to feedback and corrections.
#medtwitter #hematology #internalmedicine #classicalhematology
#medtwitter #hematology #internalmedicine #classicalhematology
1/Immune hemolytic anemia
Broadly divided into three groups:
Autoimmune hemolytic anemia (AIHA)
Alloimmune hemolytic anemia
Drug induced immune hemolytic anemia
We will discuss AIHA in this 🧵
Broadly divided into three groups:
Autoimmune hemolytic anemia (AIHA)
Alloimmune hemolytic anemia
Drug induced immune hemolytic anemia
We will discuss AIHA in this 🧵
2/AIHA - Major categories
Warm autoimmune hemolytic anemia (WAIHA)
Cold agglutinin disease (CAD)
Paroxysmal cold hemoglobinuria (PCH)
Mixed-type AIHA
Warm autoimmune hemolytic anemia (WAIHA)
Cold agglutinin disease (CAD)
Paroxysmal cold hemoglobinuria (PCH)
Mixed-type AIHA
1/ The June 2021 Edition of MDA Fellows JCWatch 📰 is now available❗️ Check out all 6️⃣ #journalclub summaries below 👇🏽 that cover GU, GI, & breast medical oncology ➕ classical hematology & SCT! #meded @MDanmolsingh @HemOncFellows @HOJournalClub @Hemoncq @MDAndersonNews
2/ First up, Dr. Ferreri presented an interesting article evaluating the potential to classify tumor microenvironments into one of four subtypes to predict response to immunotherapy ⚡️ 🔗pubmed.ncbi.nlm.nih.gov/34019806/ 
3/ Next, Dr. @FasaAgbedia presented the results of the phase 3️⃣ ASCENT trial that demonstrated ⬆️ OS and ⬆️ PFS w/ sacituzumab govitecan vs standard single agent chemotherapy in pretreated metastatic TNBC #bcsm 🔗pubmed.ncbi.nlm.nih.gov/33882206/
